Rising drug prices in Brazil during COVID-19 pandemic: another threat to people's health
Braz. J. Pharm. Sci. (Online)
;
58: e20863, 2022. tab
Artículo
en Inglés
|
LILACS-Express
| LILACS
| ID: biblio-1420412
ABSTRACT
Abstract The COVID-19 pandemic puts the healthcare systems at risk due to the still uncertain operational and financial impacts of it. The difficult economic conditions of the population also call for more attention from government officials to define strategies that guarantee access to health services and products. Maintaining the supply chain of pharmaceutical products is not only paramount to cover the immediate medical response but will be fundamental to reducing disruption of the healthcare system. Increasing drug prices during the pandemic is definitely not a strategy that contributes to access. In this sense, this commentary presents a criticism of a decision by the Brazilian government that may impact the availability in health services and the population's access to medicines necessary for the maintenance of life.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Tipo de estudio:
Evaluación Económica en Salud
País/Región como asunto:
America del Sur
/
Brasil
Idioma:
Inglés
Revista:
Braz. J. Pharm. Sci. (Online)
Asunto de la revista:
Farmacologia
/
Teraputica
/
Toxicologia
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Federal University of Santa Catarina/BR
/
University of Brasília/BR
Similares
MEDLINE
...
LILACS
LIS